Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.
Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page, reflecting a version bump. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a California Locations section to list the site locations. Updated page revision to v3.3.3.SummaryDifference0.2%
- Check53 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed in the study's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check60 days agoChange DetectedRemoved the notice that information may be outdated due to a lapse in government funding, including references to cc.nih.gov and opm.gov for operating status.SummaryDifference0.4%
- Check75 days agoChange DetectedThe update appears to be a UI redesign and minor textual edits on the Study Details pages; core data like eligibility criteria, study outcomes, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check103 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference4%
Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.